The US Preventive Services Task Force conducted a review of trials and cohort studies to support an update of its cervical cancer screening recommendations for women ages 21 to 65 and older.
from Latest articles from Cancer Therapy Advisor News https://ift.tt/2ByDEBS
from Latest articles from Cancer Therapy Advisor News https://ift.tt/2ByDEBS